Fundraising Fox

Amel Tounsi

Investor

Investment Manager at Meusinvest (Noshaq)

Brussels

Writes $100K – $5M checks · typically $1.5M

Find your path to Amel

289 people in our graph share verified history with Amel — schools, employers, funds. One of them is your warm intro.

Alexander CarlierunlockedAmel: together at Solvay Brussels School of Economics and Management (2016–2017)
×4Amel: together at Solvay Brussels School of Economics and Management
×3Amel: together at University of Strasbourg
×2Amel: together at Université catholique de Louvain

About

Amel Tounsi is Chief Executive Officer at Bridge to Health and Investment Manager at Noshaq. With over 15 years of leadership experience in biotech, advanced therapies, and health innovation ecosystems, he holds a scientific background in immunology and cell therapy. In his current roles, Tounsi has led regional and cross-border collaborations and worked to develop integrated health innovation systems across multiple sectors.

Experience

  1. Bridge to HealthChief Executive Officercurrent2022 — presentLiège
  2. NoshaqInvestment Managercurrent2021 — present
  3. Texere BiotechChief Operations Officer2018 — 2021
  4. Texere BiotechChief Operating Officer2017 — 2020
  5. MaSTherCellProject & Development Manager2014 — 2017
  6. MaSTherCellProject Manager2014 — 2017
  7. Cardio3 BiosciencesProject Lead2013 — 2014
  8. Cardio3 BiosciencesResearch And Development Scientist2011 — 2013
  9. Cardio3 BiosciencesR&D Scientist2011 — 2013
  10. CelyadProject Leader2013 — 2014
  11. DKFZPost Doctoral Fellow2009 — 2010Heidelberg Area, Germany
  12. Ludwig Institute for Cancer ResearchPhD Student2004 — 2008Brussels Area, Belgium

Skills & more

Youth MentoringTransfer to Production

Languages Arabic · English

From Amel's professional profile.

Colleagues at Meusinvest (Noshaq)

Alain Balthazart
Head of Agro at Meusinvest (Noshaq)
Anne-Charlotte Hanozin
Project Manager Immo at Meusinvest (Noshaq)
Anne-Sophie Denis
Finance & Investment Manager at Meusinvest (Noshaq)
Ariane Tissaen
Payroll & HR Officer at Meusinvest (Noshaq)
Arnaud Nizet
Technical Manager Immo at Meusinvest (Noshaq)
Aude Lamby
Legal Assistant at Meusinvest (Noshaq)
Benoit Fellin
Fund Director at White Fund
Bertrand Gascard
Communication Officer at Meusinvest (Noshaq)

Network7

Alain Balthazart
Head of Agro at Meusinvest (Noshaq)
Benoit Fellin
Fund Director at White Fund
Bertrand Joiret
Investment Manager at Meusinvest (Noshaq)
Christine Gerardy
Head of Funding & Strategic Plan Monitoring at Meusinvest (Noshaq)
Gaëtan Baudelet
Investment Manager at Meusinvest (Noshaq)
Gaëtan Gottschalk
Project Manager Immo at Meusinvest (Noshaq)
Thomas Chevau
Development Manager Immo at Meusinvest (Noshaq)

Investors connected to Amel in public investor directories — a warm-intro map.

Frequently asked questions

Who is Amel Tounsi?
Amel Tounsi is Chief Executive Officer at Bridge to Health and Investment Manager at Noshaq. With over 15 years of leadership experience in biotech, advanced therapies, and health innovation ecosystems, he holds a scientific background in immunology and cell therapy. In his current roles, Tounsi has led regional and cross-border collaborations and worked to develop integrated health innovation systems across multiple sectors.
Where does Amel Tounsi work?
Amel Tounsi is Investment Manager at Meusinvest (Noshaq).
What check size does Amel Tounsi write?
Amel Tounsi typically writes checks of $100K – $5M.
Where did Amel Tounsi go to school?
Amel Tounsi studied at Solvay Brussels School of Economics and Management (Accelerated Management Programme, LEadership-Project Managment-Marketing-Accounting-Finance-Strategic Management); Université catholique de Louvain (PhD, Biomedical studies); European Directorate for the Quality of Medicines & HealthCare (Symposium on Raw Materials for the Production of Cell-based and Gene Therapy Products').

Same school

Also attended Université catholique de Louvain104

Iñigo López-HuertaCFO at Ysios CapitalCharles de LiedekerkeInvestor at Inventures Investment PartnersPaul VarassoPrincipal at Axeleo CapitalJérôme WittamerCo-founder and Managing Partner at Expon CapitalYves TrouveroyInvestment Partner at E-Capital Equity ManagementVincent BrichardVenture Partner at EQT Life Sciences

+ 98 more

Also attended University of Strasbourg31

Steven BohnFinancial Controller at Partech VenturesGrégoire KairysCompliance & Internal Control at Iris CapitalBill PowellCo-Founder & Managing Partner — IC Chair at Anthropy PartnersPierre SochaPartner at Amadeus Capital PartnersSigurdur ArnljotssonFounding Partner at Brunnur Ventures GPHansjörg SagePartner at LeadX Capital Partners

+ 25 more

Shared employers

Also worked at Texere Biotech1

Dr. Denis DufraneFounder & Professor at Novadip

Also worked at Celyad5

Rudy DekeyserPartner, Head of Health Economic Funds at EQT Life SciencesVincent BrichardVenture Partner at EQT Life SciencesChris BuyseBoard Member at Fund+Simon BornscheinCo-founder & CEO at Coding BioRudy DekeyserGeneral Partner at EQT Health Economics Cooperatief

Also worked at DKFZ12

Kirsten LeutePartner at Osage University PartnersIsabel ZhangInvestor at HCVCStella PaffenholzSenior Associate at Atlas VentureKerstinDirector, Pharma at Deep Science VenturesJulien ElricSenior Principal at Jeito CapitalCindy WeiInvestment Team - TechBio at Lunar Ventures

+ 6 more

Also worked at Ludwig Institute for Cancer Research8

Karen KnudsenAdvisor at Oncology VenturesVincent BrichardVenture Partner at EQT Life SciencesYann EchelardPartner, PhD at ORI CapitalKhatereh AhmadiVenture Partner at XGEN VentureJill WykoskyVenture Partner at RA CapitalLeonardo TeixeiraFounder at Endpoint Health

+ 2 more